Monoclonal antibody reduces asthma attacks in urban youth NIAIDNews TheLancet
, which is available with the full text of this article at NEJM.org, was developed by the sponsor, GlaxoSmithKline. The first draft of the manuscript was written by the first author, an employee of GlaxoSmithKline; editorial support funded by GlaxoSmithKline was provided by Gardiner-Caldwell Communications. Data were collected by the investigators and analyzed by employees of the sponsor.
Exacerbations were confirmed by objective changes that patients recorded daily in an electronic diary .At each clinic visit, we evaluated results of spirometric and hematologic tests and administered the 5-item Asthma Control Questionnaire , on which scores range from 0 to 6, with higher scores indicating worse function, and 0.5 is the minimal clinically important difference between scores. At randomization and the final study visit, we administered the St.
Safety was evaluated by an assessment of adverse events, vital signs, electrocardiographic findings, and immunogenicity, along with clinical laboratory testing. Levels of antibodies against mepolizumab were measured before randomization and at three time points after randomization.All patients who received at least one dose of a study drug were included in a modified intention-to-treat analysis.
that included covariates for treatment, use of maintenance oral glucocorticoids, geographic region, number of exacerbations in the previous year, and baseline percentage of the predicted FEV. We estimated that with 180 patients in each group, the study would have a power of 90% to detect a 40% decrease in the exacerbation rate, from 2.40 per year in the placebo group to 1.44 per year in each of the mepolizumab groups, at a two-sided significance level of 0.05.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
'I've been let down - I shouldn't have stage-4 cancer''This is an absolute disaster' Imperial College London's prof_price tells Newsnight delays in care is the worst cancer crisis she's seen in her lifetime. 📺 Full report tonight on BBC 2 at 22.30
Read more »
Huge new 'super salon' to open in Merseyside this yearThe salon will feature luxury treatment rooms and a training school for VTCT laser and skin rejuvenation students 🙌
Read more »
The best tried and tested chickenpox treatmentsMother&Baby roundup the best Chickenpox This buyer’s guide includes who to spot chickenpox and the best over-the-counter treatments.
Read more »
Almost 90% of subjects who experience COVID-19-linked taste or smell dysfunction fully recover after two yearsAlmost 90% of subjects who experience COVID-19-linked taste or smell dysfunction fully recover after two years UniPadova COVID19 Coronavirus SARSCoV2 Anosmia Smell Taste Dysfunction
Read more »
All the Watford dentists accepting NHS patientsAs nine in 10 NHS dentists in the UK stop accepting new adult patients, we've rounded up the Watford dentists that are.
Read more »